HomePMVP • NASDAQ
add
PMV Pharmaceuticals Inc
Previous close
$1.37
Day range
$1.36 - $1.44
Year range
$1.32 - $2.26
Market cap
74.00M USD
Avg Volume
179.33K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 21.89M | 11.51% |
Net income | -19.23M | -15.54% |
Net profit margin | — | — |
Earnings per share | -0.37 | -8.82% |
EBITDA | -21.52M | -11.66% |
Effective tax rate | -0.39% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 182.84M | -9.45% |
Total assets | 223.50M | -14.38% |
Total liabilities | 25.59M | 9.28% |
Total equity | 197.91M | — |
Shares outstanding | 51.75M | — |
Price to book | 0.36 | — |
Return on assets | -23.74% | — |
Return on capital | -24.96% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -19.23M | -15.54% |
Cash from operations | -16.84M | -7.54% |
Cash from investing | 17.12M | 150.89% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | 284.00K | 101.76% |
Free cash flow | -9.91M | -5.48% |
About
Founded
2013
Website
Employees
63